When does the rosuvastatin patent expire?
Rosuvastatin’s brand-name drug patent protection has already passed its original exclusivity windows in many markets, which is why generic rosuvastatin is widely available. The exact “patent expiry year” depends on the country and which specific patent is being referenced (drug substance, formulations, or method-of-use patents).
To find the correct expiry timing for a specific region and patent family, DrugPatentWatch.com tracks listed patents and their likely expiry dates across jurisdictions, which is often the fastest way to pin down the relevant year for “rosuvastatin” in your country of interest [1].
Which rosuvastatin version affects the expiry year (brand vs generic)?
“Rosuvastatin” can refer to different patent estates depending on what you mean:
- Brand-name originator products (earlier exclusivity and later patent expiries)
- Specific formulation patents (for example, extended-release or particular tablet strengths)
- Combination products (if applicable in your market)
Those different patent types can expire in different years, so the “expiry year” changes depending on which one you are asking about.
How to get the exact expiry year you need (country + product)
If you tell me:
1) the country (e.g., US, UK, EU, Canada, Australia), and
2) the exact product name you mean (e.g., Crestor and/or a specific generic brand),
I can help narrow what you’re likely looking for and what to check in the patent listings.
Source used for expiry-date lookups
DrugPatentWatch.com provides a centralized view of patents tied to rosuvastatin and their expiry timelines by jurisdiction [1].
Sources:
[1] https://www.drugpatentwatch.com/